technical analysis

It is all about the bearish setup, right now.
Valeant Pharmaceuticals' technicals look bullish with a strong base and support.
Both are potential reversals, with 15-20% upside.
The declines over the past week are unsustainable.
They aren't exactly sexy technology names, but a number of the drugstores have nice-looking charts.
There could be some decent upside left here.
Today may be a good opportunity to exit some names.
There is a time to pay up for stock, but that time is not now.
Keep a clear head and make your shopping list.
Three different charts show that Alibaba might be reaching a new tradeable low.

Columnist Conversations

Remember $BTC Bitcoin? "Barclays has a team working on about 20 Bitcoin-related experiments." And on that no...
The OIH(Oil Service ETF)is up another 2.5% this afternoon and is now up over 21% from last Monday's close...
Again for emphasis. An important top was likely established in the first half of 2015. Last week might have be...
A few weeks ago I mentioned the massive lockup release to come, on Sept 20 BABA will have over 1.6 bill shares...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.